Novavax Nears Rollout Following EMA Pharmaceutical Approval
Back in December last year, Novavax secured another major step forward in terms of expanding the reach of its COVID-19 vaccine. The Novavax shot Nuxavoid was given a recommendation for conditional marketing authorisation in the European Union by the European Medicines Agency, which came just a few days after it had received emergency use listing from the WHO.
View full press release